Form 4: Director D. Mark Durcan Increases Stake in Cencora
Statement of Changes in Beneficial Ownership
Cencora, Inc. Director D. Mark Durcan purchased 4,000 shares of common stock at a price of $266.26 per share.
Summary
- Director D. Mark Durcan acquired 4,000 shares of Cencora, Inc. (COR) common stock.
- The transaction occurred on May 28, 2026, at a price of $266.26 per share.
- Following this transaction, the director's total beneficial ownership increased to 27,767 shares.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as director-level insider buying typically reflects confidence in the company's future performance.
Positives
- Insider confidence is demonstrated by the director's open-market purchase of company stock.
Negatives
- None identified in this filing.
Risks
- None identified in this filing.
Future Outlook
Not applicable for this filing type.
Industry Context
StockSavvy.ai notes that insider buying is generally viewed as a positive signal regarding management's outlook on the company's long-term value and financial stability within the pharmaceutical distribution sector.
Comparison to Industry Standards
- Insider purchases by board members are standard corporate governance activities and align with industry norms for publicly traded healthcare companies.
Stakeholder Impact
- Shareholders may interpret this purchase as a sign of internal confidence in the company's strategic direction.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 05/28/2026 | Date of the reported stock purchase transaction. |
Keywords
Cencora, COR, Insider Trading, Form 4, D. Mark Durcan, Stock Purchase
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.